Human epidermal growth factor excreted by recombinant Escherichia coli K-12 has the correct N-terminus and is fully bioactive

Process Biochemistry

Volumn 35, Issue 1-2, 1999, Pages 1-5

  Huang, R C ^a   Lam, E ^a   Chen, Y H ^a   Hackett, J ^a   Lam, T L ^a   Liu, D ^b   Ma, M C ^c   Siu, K L ^a   Sivakesava, S ^a   Xu, Z N ^a   Wong, R S C ^a   Wong, W K R ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b PFIZER INC   (United States)

^c Bldg 142   (United States)

Author keywords

Bioassay; Excretion; Fermentation; HEGF

Indexed keywords

EPIDERMAL GROWTH FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOASSAY; ESCHERICHIA COLI K 12; FERMENTATION; GENETIC RECOMBINATION; ION EXCHANGE CHROMATOGRAPHY; NONHUMAN;

BACTERIA (MICROORGANISMS); ESCHERICHIA; ESCHERICHIA COLI K12;

EID: 0032716415     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0032-9592(99)00024-2     Document Type: Article

References (21)

1. Hollenberg M.D., Gregory H. Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts. Life Sci. 20:1997;267-274.
2. Zoller M.J., Smith M. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 10:1982;6487-6500.
3. Cuatrecasas P. Isolation of the insulin receptor of liver and fat cell membranes. Proc. Natl. Acad. Sci. USA. 69:1972;318-322.
4. Oka T., Sakamato S., Miyoshi K.I., Fuwa T., Yoda K., Yamasaki M., Tamura G., Miyake T. Synthesis and secretion of human epidermal growth factor by Escherichia coli. Proc. Natl. Acad. Sci. USA. 82:1985;7212-7216.
5. Shimizu N., Fukuzono S., Harada Y., Fujimori K., Gotoh K., Yamazaki Y. Mass production of human epidermal growth factor using fed-batch cultures of recombinant Escherichia coli. Biotechnol. Bioeng. 38:1991;37-42.
6. Kim E., Fu J., Wilson D.B., Shuler M.L. Expression of human epidermal growth factor by Escherichia coli in continuous culture. Biotechnol. Lett. 14:1992;339-344.
7. Ebisu S., Takagi H., Kadowaki K., Yamagata H., Udka S. Production of human epidermal growth factor by Bacillus brevis increased with use of a stable plasmid from B. brevis 481. Biosci. Biotechnol. Biochem. 56:1992;812-813.
8. Yadwad V.B., Wilson S., Ward O.P. Production of human epidermal growth factor by an ampicillin-resistant recombinant Escherichia coli strain. Biotechnol. Lett. 16:1994;885-890.
9. Skipper N., Sutherland M., Davies R.W., Kilburn D., Miller R.C. Jr., Warren A., Wong R. Secretion of a bacterial cellulase by yeast. Science. 230:1985;958-960.
10. Wong W.K.R., Curry C., Parekh R.S., Parekh S.R., Wayman M., Davies R.W., Kilburn D.G., Skipper N. Wood hydrolysis by Cellulomonas fimi endoglucanase and exoglucanase coexpressed as secreted enzymes in Saccharomyces cerevisiae. Bio/Technology. 6:1988;713-719.
11. Wong W-KR, Sutherland ML. Excretion of heterologous proteins from Escherichia coli. US Patent no. 5,223,407, 1993.
12. Lam T.-L., Wong R.S.C., Wong W.K.R. Enhancement of extracellular production of a Cellulomonas fimi exoglucanase in Escherichia coli by the reduction of promoter strength. Enzyme Microb. Technol. 20:1997;482-488.
13. Wong W.K.R., Ali A., Chan W.K., Ho V., Lee N.T.K. The cloning, expression and characterization of a cellobiase gene encoding a secretory enzyme from Cellulomonas biazotea. Gene. 207:1998;70-86.
14. Lam K.H.E., Chow K.C., Wong W.K.R. Construction of an efficient Bacillus subtilis system for extracellular production of heterologous proteins. J. Biotechnol. 63:1998;167-177.
15. Wong D.K.-H., Lam K.H.E., Chan C.K.P., Wong Y.C.V., Wong W.K.R., Hackett J. Extracellular expression of human epidermal growth factor by an Escherichia coli K-12 plasmid stabilized by the ytl2-incR system of Salmonella typhimurium. J. Ind. Microbiol. Biotechnol. 21:1998;31-36.
16. Enfors S.O. Control of in vivo proteolysis in the production of recombinant proteins. Trends Biotechnol. 10:1992;310-315.
17. Hasegawa N., Yamonoto K. Epidermal growth factor suppresses in vitro senescence in the ability of human umbilical vein endothelial cells to proliferate, but not in the ability to produce prostacyclin. Mech. Ageing Dev. 66:1992;107-114.
18. Brown GL. Method of decreasing cutaneous senescence. US Patent no. 5,618,544, 1997.
19. Sivakesava S, Xu ZN, Chen YH, Hackett J, Huang RC, Lam E, Lam TL, Siu KL, Wong RSC, Wong WKR. Production of excreted human epidermal growth factor (hEGF) by an efficient recombinant Escherichia coli system. Process Biochem. 1999;in press.
20. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning - A Laboratory Manual. 2nd ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Schagger H., Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Chem. 166:1987;368-379.